Resistance to apoptosis underpins the corticosteroid insensitivity of group 2 innate lymphoid cells
CAPSULE SUMMARY: Out of all type-2 immune cells, only ILC2s withstand corticosteroid treatment due to a reduced pro-apoptotic machinery. The findings may advance the understanding on the mechanism in steroid-resistant diseases and facilitate the development of improved therapies.
Main Authors: | Luo, J, Wu, Y, Shrimanker, R, Go, S, Ye, Y, Hardman, C, Nahler, J, Chen, Y, Stöger, L, Zeng, N, Liu, W, Reed, L, Tolkovsky, A, Klenerman, P, Ogg, G, Pavord, I, Xue, L |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
Elsevier
2019
|
Registos relacionados
-
Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function
Por: Hardman, C, et al.
Publicado em: (2019) -
Investigating functions of human group 2 innate lymphoid cells in health and disease
Por: Nahler, J
Publicado em: (2021) -
IL-6 effector function of group 2 innate lymphoid cells (ILC2) is NOD2 dependent
Por: Hardman, CS, et al.
Publicado em: (2021) -
Cytometric gating stringency impacts on studies of type 2 innate lymphoid cells in asthma
Por: Hinks, T, et al.
Publicado em: (2017) -
Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
Por: Chen, W, et al.
Publicado em: (2018)